LANDMARK TRIAL TO EVALUATE CARDIO PROTECTIVE PROPERTIES OF INSULIN
November 09, 2007
November 09, 2007
BUFFALO, N.Y., Nov. 9 -- The University at Buffalo issued the following press release:
The ability of insulin to limit heart-tissue damage during a heart attack will be tested in a landmark clinical trial led by Paresh Dandona, M.D., Ph.D., University at Buffalo Distinguished Professor in the departments of Medicine and Pharmacology and Toxicology in the UB School of Medicine and Biomedical Sciences.
Approximately 600 patients at 90 centers in the U.S. and Latin Ame . . .
The ability of insulin to limit heart-tissue damage during a heart attack will be tested in a landmark clinical trial led by Paresh Dandona, M.D., Ph.D., University at Buffalo Distinguished Professor in the departments of Medicine and Pharmacology and Toxicology in the UB School of Medicine and Biomedical Sciences.
Approximately 600 patients at 90 centers in the U.S. and Latin Ame . . .